VPT — VentriPoint Diagnostics Share Price
0.000.00%
Last trade - 00:00- CA$22.01m
- CA$23.30m
- CA$0.05m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 161.17 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -3650.89% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 0.08 | 0.04 | n/a | 0.07 | 0.05 | n/a | n/a | -3.96% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.
Directors
- George Adams CHM (70)
- Victor Hugo CFO
- Alvira Macanovic VOP
- Robert Hodgkinson IND
- Hugh MacNaught IND
- Peter Weichler IND
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- September 18th, 2007
- Public Since
- November 9th, 2005
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 163,057,280
- Address
- 18 Hook Ave, Unit 101, TORONTO, M6P 1T4
- Web
- https://www.ventripoint.com
- Phone
- +1 4168484156
- Contact
- Jonathan Robinson
- Auditors
- MNP LLP
Upcoming Events for VPT
Q4 2024 VentriPoint Diagnostics Ltd Earnings Release
Q1 2025 VentriPoint Diagnostics Ltd Earnings Release
Q2 2025 VentriPoint Diagnostics Ltd Earnings Release
Similar to VPT
Aurora Spine
TSX Venture Exchange
CardioComm Solutions
TSX Venture Exchange
Conavi Medical
TSX Venture Exchange
Covalon Technologies
TSX Venture Exchange
EvokAI Creative Labs
TSX Venture Exchange
FAQ
What is the VentriPoint Diagnostics share price?
As of Today at 23:56 UTC, shares in VentriPoint Diagnostics are trading at CA$0.14. This share price information is delayed by 15 minutes.
How has the VentriPoint Diagnostics share price performed this year?
Shares in VentriPoint Diagnostics last closed at CA$0.14 and the price had moved by -35.71% over the past 365 days. In terms of relative price strength the VentriPoint Diagnostics share price has underperformed the Toronto Stock Exchange 300 Composite Index by -42.05% over the past year.
What are the analyst and broker recommendations for VentriPoint Diagnostics?
There is no consensus recommendation for this security.
Find out moreWhat is the VentriPoint Diagnostics dividend yield?
VentriPoint Diagnostics does not currently pay a dividend.
Does VentriPoint Diagnostics pay a dividend?
VentriPoint Diagnostics does not currently pay a dividend.
When does VentriPoint Diagnostics next pay dividends?
VentriPoint Diagnostics does not currently pay a dividend.
How do I buy VentriPoint Diagnostics shares?
To buy shares in VentriPoint Diagnostics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of VentriPoint Diagnostics?
As of the previous close price of CA$0.14, shares in VentriPoint Diagnostics had a market capitalisation of CA$22.01m.
Where are VentriPoint Diagnostics shares listed?
Here are the trading details for VentriPoint Diagnostics:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: VPT
What kind of share is VentriPoint Diagnostics?
Based on an overall assessment of its quality, value and momentum VentriPoint Diagnostics is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a VentriPoint Diagnostics share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the VentriPoint Diagnostics share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like VentriPoint Diagnostics. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -13.77%.
As of the last closing price of CA$0.14, shares in VentriPoint Diagnostics were trading -9.01% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the VentriPoint Diagnostics PE Ratio?
The VentriPoint Diagnostics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.14.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of VentriPoint Diagnostics?
VentriPoint Diagnostics' management team is headed by:
- George Adams - CHM
- Victor Hugo - CFO
- Alvira Macanovic - VOP
- Robert Hodgkinson - IND
- Hugh MacNaught - IND
- Peter Weichler - IND